profit from every ₹100 of sales.
₹0₹100
DR Agarwals Health CARE L
₹554.15+3.14% today
+9.6% in 1 year
1-year low ₹406.551-year high ₹560.70
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2026.
0%20% a year
You pay ₹131.93 for every ₹1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What DR Agarwals Health CARE L sold, what it kept, and what it did with the cash.
Sales went from ₹10.2 billion in 2023 to ₹20.8 billion in 2026, with ₹1.33 billion of profit last year.
SalesProfit
DR Agarwals Health CARE L handed back 2% of the cash it generated last year.
₹11M
Free cash flow 2026₹584M
Bought back its own shares–
Paid as dividends₹11M
Cash vs. debt₹906M vs. ₹10.7B
DR Agarwals Health CARE L vs. similar companies
DR Agarwals Health CARE L grows the fastest of these 5 and is the most expensive for its profits.
| Company | Profit from ₹100 of sales | Sales growth a year | Price per ₹1 of profit |
|---|---|---|---|
| DR Agarwals Health CARE L | 131.9× · Very expensive | ||
 Intuitive Surgical | 54.6× · Expensive | ||
 EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Becton, Dickinson and | 34.8× · Expensive | ||
 Medline | 47.9× · Expensive |
AI analysis
An AI analyst reads DR Agarwals Health CARE L's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 10,165 | 13,277 | 17,110 | 20,801 | |
| 4,579 | 5,991 | 10,756 | 13,282 | |
| 1,536 | 2,019 | 2,256 | 2,933 | |
| 2,839 | 4,066 | 4,994 | 6,153 | |
| 941 | 831 | 835 | 1,332 | |
| 2.98 | 2.63 | 2.78 | – | |
| 45.1% | 45.1% | 62.9% | 63.9% | |
| 15.1% | 15.2% | 13.2% | 14.1% | |
| 9.3% | 6.3% | 4.9% | 6.4% |
Balance sheet
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Total assets | 18,252 | 27,528 | 36,716 | 39,418 |
| Cash | 1,270 | 1,118 | 1,036 | 906 |
| Total debt | 8,573 | 9,664 | 9,609 | 10,662 |
| Total liabilities | 11,661 | 13,733 | 17,448 | 18,221 |
| 6,296 | 13,394 | 18,666 | 20,255 | |
| 316 | 316 | 300 | – | |
| 7.8% | 7.7% | 7.1% | 8.2% | |
| 14.9% | 6.2% | 4.5% | 6.6% |
Cash flow
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 2,331 | 3,460 | 3,571 | 5,190 | |
| 1,578 | 2,323 | 3,209 | 4,606 | |
| 753 | 1,137 | 362 | 584 | |
| Dividends paid | 4 | 8 | 8 | 11 |
| – | – | – | – | |
| 18 | 51 | 84 | 74 |
Valuation
- 131.9×
- –
- –
- 6.9×
- 8.4×
- 300.8×
- 30.1×
- 0.3%
- 0.8%
- 0.0%
Profitability
- 63.9%
- 14.1%
- 6.4%
- –
- 8.2%
- 7.7%
- –
- –
- –
- –
Growth
- +27.0%
- –
- –
- –
- −1.7%
Financial health
- 1.6×
- 0.53
- –
- 3.7×
- 1.24
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 37%of 958
Top 37%of 888
Bottom 6%of 600
Top 20%of 889
Bottom 42%of 987
0.0%of the share price, paid each year
On $1,000 invested$0a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
0.8% of its profit
Room to growStretchedMore than it earns: 1.9%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
40No pass
Benjamin Graham
32No pass
Philip Fisher
48No pass
Peter Lynch
79Pass
Joel Greenblatt
4No pass
Charlie Munger
28No pass
Terry Smith
24No pass
Questions about DR Agarwals Health CARE L
Is DR Agarwals Health CARE L a good stock to buy?
A business with weak numbers, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the DR Agarwals Health CARE L AI analysis
What does DR Agarwals Health CARE L do?
Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It is in Medical Instruments & Supplies, based in Chennai, India.
Does DR Agarwals Health CARE L pay a dividend?
Yes. At today's price the dividend is 0.0% a year, about 1% of its yearly profit. In 2026 it paid out ₹10.9 million in dividends.
Is DR Agarwals Health CARE L stock halal?
Yes. DR Agarwals Health CARE L passes our halal screen: its business is permitted and its debt is 6% of its market value, under the 30% limit. How we check
How has DR Agarwals Health CARE L stock done over the past year?
Up 9.6% over the past twelve months, to ₹554.15. It traded between ₹406.55 and ₹560.70, close to its high.
Who are DR Agarwals Health CARE L's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with DR Agarwals Health CARE L's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.